Australia markets closed

QURE Oct 2024 7.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.26000.0000 (0.00%)
As of 02:32PM EDT. Market open.
Full screen
Previous close0.2600
Open0.2600
Bid0.0000
Ask2.0500
Strike7.00
Expiry date2024-10-18
Day's range0.2600 - 0.2600
Contract rangeN/A
Volume5
Open interest22
  • Simply Wall St.

    uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

    uniQure ( NASDAQ:QURE ) First Quarter 2024 Results Key Financial Results Revenue: US$8.49m (up 59% from 1Q 2023). Net...

  • GlobeNewswire

    uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

    ~ On track to initiate FDA interaction regarding AMT-130 in second quarter of 2024 and provide a clinical update from the Phase I/II trials in mid-2024 ~ ~ Clinical trial initiation for Fabry disease on track to begin in second quarter of 2024, followed by refractory mesial temporal lobe epilepsy and SOD1-ALS in third quarter of 2024 ~ ~ Comprehensive review of operations and options to reduce expenses underway and expected to be completed in mid-2024 ~ LEXINGTON, Mass. and AMSTERDAM, May 07, 20

  • Insider Monkey

    13 Best Biotech Stocks To Buy Under $20

    In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]